ࡱ > [ U bjbj . kiki> B B B B B V V V V V $ ~ ? B ? B B Z B B ȇ 0 ! ( ! ! B D ? ?
! X : SAMPLE BASIC SCIENCE APPLICATION
ABSTRACT:
TITLE: Smooth Muscle Cells effect on the angiogenic invasion of Human-Umbilical Vein Endothelial Cells in fibrin- based Tissue Engineered Blood Vessels Analogs subjected to 10% 3-D Cyclic Strain
INTRODUCTION:
T i s s u e s g r e a t e r t h a n 2 0 0 m f r o m a v a s c u l a r s u p p l y a r e s u s c e p t i b l e t o b o t h i s c h e m i a a n d s u b s e q u e n t n e c r o s i s . E n g i n e e r e d t i s s u e s , i n c l u d i n g t i s s u e e n g i n e e r e d b l o o d v e s s e l s ( T E B V s ) , h a v e t h e s a m e r e q u i r e m e n t s . A s s u c h , t h e d e v e l o p m e n t o f g r a f t s w i t h t h i c k e r media layers will likely require the development of a microvasculature within these vessels walls to nourish the smooth muscle cells (SMCs) of the tunica media which add both structural integrity and elasticity. ADDIN EN.CITE Folkman197319191917Folkman, J.Hochberg, M.Self-regulation of growth in three dimensionsJ Exp MedJ Exp Med745-5313841973/10/01AgarAnimalsCell Count*Cell DivisionCricetinae*Culture TechniquesLeukemia, Experimental/pathologyLung/pathologyMelanoma/pathologyMiceTime Factors1973Oct 10022-1007 (Print)4744009http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=47440092180571eng(1) Recent developments in tissue culture techniques have demonstrated that dynamic mechanical stimulation can augment cellular proliferation, alignment, and matrix protein synthesis. To achieve these same benefits TEBVs have been cultured with dynamic mechanical stimulation. Cyclic strain has been shown to particularly augment the mechanical strength of TEBVs. ADDIN EN.CITE ADDIN EN.CITE.DATA (2) Preliminary results within the lab of Dr. Howard Greisler have shown that, when compared to static controls, endothelial cells (ECs) seeded alone within fibrin-based TEBVs and cultured in a dynamic environment of 10% cyclic strain demonstrate shorter, more robust, and wider multi-cellular angiogenic sprouts. Additionally, work in the same lab has shown that ECs co-cultured with SMCs (both homogenous distribution and co-aggregated) in a fibrin matrix have both longer and more robust angiogenic sprouting.
HYPOTHESIS:
Within a dynamic culture environment, the homogenous addition of SMCs to the extracellular matrix will augment the development and angiogenic invasion of EC sprouts into a fibrin hydrogel.
METHODS:
TEBVs will be formed from fibrin, over silicone sleeves. Prior to formation of the TEBV and pelleting of the ECs, both cell types identities will be confirmed using immunohistochemistry and then labeled seperatly with two distinct membrane bound immunoflourescent surface dyes. A tubular hydrogel will be formed from a suspension of human-umbilical vein EC (HUVEC) pellets (2k cells/pellet, 20 pellets/mL), canine carotid SMCs (100k /mL), fibrinogen (2.5mg/mL), thrombin (0.32 U/mL), heparin (5U/mL), vascular endothelial growth factor (VEGF) (1 ng/mL), fibroblast growth factor-1 (FGF-1) (10ng/mL), and aprotinin (100KIU/mL). The hydrogel TEBV analog will then be mounted within a bioreactor chamber. The constructs will then be covered with assay media comprised of all of the same reagents and concentrations as the TEBV except the cells, fibrinogen and thrombin. This media will be replaced every 3 days. A Windkessel effect pump system will deliver fluid pulsations through the bioreactor distending the TEBV another 10% of the silicones sleeves original volume. Angiogenic invasion will be documented at Day 7 by measuring average sprout length and sprout number by both light and confocal fluorescence microscopy. The samples that have large multi-cellular sprouts will be sent for TEM sectioning and imaging to confirm lumen formation
ANTICIPATED RESULTS:
ECs and SMCs co-cultured in a fibrin-based TEBV subjected to 10% 3-D cyclic strain will likely demonstrate a robust network of angiogenic sprouts that are longer than sprouts formed by endothelial cells alone and wider than sprouts formed in co-culture without mechanical stimulation.
Research Plan:
Background and rationale
Tissue Engineered Blood Vessels: The current standard for small diameter (<6mm) functional arterial grafts in vascular medicine is the autologous graft. The use of these grafts is limited in many patients since a suitable replacement is not available due to vascular disease, amputation, or previous harvests. Experiments have shown that with lower flow velocities in the smaller grafts, the incidence of thrombogenesis, aneurysm formation, and atherosclerotic plaque formation is increased. There is currently a need for an alternative option for small diameter functional arterial grafts, and this absence has spurred interest into TEBVs. ADDIN EN.CITE Barron200344417Barron, V.Lyons, E.Stenson-Cox, C.McHugh, P. E.Pandit, A.National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Galway, Ireland. valerie.barron@nuigalway.ieBioreactors for cardiovascular cell and tissue growth: a reviewAnn Biomed EngAnn Biomed Eng1017-303192003/10/30AnimalsArteries/growth & developmentBiomimetics/instrumentation/methods/trends*BioreactorsCell Culture Techniques/*instrumentation/methods/trendsCoronary Vessels/*growth & developmentHeart/*growth & developmentHeart Valves/growth & developmentHumansMyocytes, Cardiac/*physiologyTissue Engineering/*instrumentation/*methods/trends2003Oct0090-6964 (Print)14582605http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14582605eng(3) Originally described by Weinberg and Bell, TEBVs are comprised of a complex network of cells and tubular support scaffolding. ADDIN EN.CITE Weinberg198612121217Weinberg, C. B.Bell, E.A blood vessel model constructed from collagen and cultured vascular cellsScienceScience397-40023147361986/01/24AnimalsAorta/anatomy & histology/cytologyBlood Vessels/*anatomy & histology/physiologyCattleCells, CulturedCollagen/*physiologyEndothelium/anatomy & histology/cytologyMicroscopy, Electron, Scanning*Models, CardiovascularMuscle, Smooth, Vascular/anatomy & histology/cytologyPolyethylene Terephthalates/diagnostic use1986Jan 240036-8075 (Print)2934816http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2934816eng(4) Within these constructs, scaffolding materials typically include synthetic alternatives as well as biologic hydrogels such as fibrin and collagen. Fibrin hydrogels have been shown to stimulate ECs and pericytes (i.e. vascular SMCs and fibroblasts) to up-regulate cellular proliferation, synthesis of cytokines and both elastin and collagen genesis. ADDIN EN.CITE Isenberg200677717Isenberg, B. C.Williams, C.Tranquillo, R. T.Department of Chemical Engineering & Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.Small-diameter artificial arteries engineered in vitroCirc ResCirc Res25-359812006/01/07AnimalsArteries/*cytology/physiologyBiocompatible MaterialsBiomechanicsBioreactorsBlood CirculationCollagenEndothelium, Vascular/physiologyFibrinHumansMuscle, Smooth, Vascular/physiologyPolymersTissue Engineering/*methods2006Jan 61524-4571 (Electronic)16397155http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1639715598/1/25 [pii]
10.1161/01.RES.0000196867.12470.84eng(5)
Dynamic Stimulation: Dynamic mechanical stimulation, within a bioreactor cell culture, has been shown to promote tissue organization in engineered constructs. ADDIN EN.CITE Ziegler199533317Ziegler, T.Alexander, R. W.Nerem, R. M.Bioengineering Center, Georgia Institute of Technology, Atlanta 30332-0405, USA.An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biologyAnn Biomed EngAnn Biomed Eng216-252331995/05/01AnimalsBlood Flow VelocityCell DivisionCell SizeCells, CulturedEndothelium, Vascular/*physiologyExtracellular Matrix/physiologyMuscle, Smooth, Vascular/*physiologyStress, MechanicalSwine1995May-Jun0090-6964 (Print)7631978http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7631978eng(6) Cyclic 2-D uniaxial strain has been shown to augment ECs migration, cytokine production, proliferation, matrix remodeling and inhibit EC apoptosis. ADDIN EN.CITE ADDIN EN.CITE.DATA (7) Dynamic culture techniques have shown that subsequent mechanical stimulation after hydrogel formation increases the constructs mechanical structural characteristics (i.e. burst pressure, suture retention strength, etc). ADDIN EN.CITE ADDIN EN.CITE.DATA (2) The dynamically conditioned TEBVs are able to develop these characteristics secondary to proliferation of the cellular components of tunica media (i.e. SMCs). As these structural layers thicken to handle their mechanical load (>200 m ) a m i c r o v a s c u l a r s u p p o r t n e t w o r k a k i n t o n a t i v e v e s s e l s v a s a v a s o r u m m u s t b e c o n s i d e r e d t o a l l o w n u t r i e n t s a n d g a s e x c h a n g e i n t o t h e d e e p e r l a y e r s o f t i s s u e . A D D I N E N . C I T E < E n d N o t e > < C i t e > < A u t h o r > F o l k m a n < / A u t h o r > < Y e a r > 1 9 7 3 < / Y e a r > < R e c N u m > 1 9 < / R e c N u m > < r e c ord>191917Folkman, J.Hochberg, M.Self-regulation of growth in three dimensionsJ Exp MedJ Exp Med745-5313841973/10/01AgarAnimalsCell Count*Cell DivisionCricetinae*Culture TechniquesLeukemia, Experimental/pathologyLung/pathologyMelanoma/pathologyMiceTime Factors1973Oct 10022-1007 (Print)4744009http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=47440092180571eng(1)
Angiogenesis: Angiogenesis is the formation of new capillary blood vessels from a pre-existing vasculature. This process consists of cellular differentiation, proliferation, and matrix invasion and subsequent tubulogenesis. Angiogenesis is influenced by cytokines present within the extra cellular matrix, cytokines secreted in a paracrine fashion from local supporting cells such as pericytes and mechanical stimulation. ADDIN EN.CITE ADDIN EN.CITE.DATA (8, 9) The ultimate cellular response to stimulation is determined secondary to summation of all these complex signaling pathways.
Co-Culture with SMCs and ECs: In vitro, ECs and SMCs secrete cytokines, which may locally influence their culture environment in a paracrine fashion. This stimulation has been shown to augment angiogenic invasion cell proliferation; for example, SMCs have been shown to locally secrete growth factors (e.g. VEGF, PDGF, etc.). ADDIN EN.CITE Ziegler199533317Ziegler, T.Alexander, R. W.Nerem, R. M.Bioengineering Center, Georgia Institute of Technology, Atlanta 30332-0405, USA.An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biologyAnn Biomed EngAnn Biomed Eng216-252331995/05/01AnimalsBlood Flow VelocityCell DivisionCell SizeCells, CulturedEndothelium, Vascular/*physiologyExtracellular Matrix/physiologyMuscle, Smooth, Vascular/*physiologyStress, MechanicalSwine1995May-Jun0090-6964 (Print)7631978http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7631978eng(6) Co-cultures using myoblasts and ECs have been shown to stimulate lumen formation as well as vessel network formation. ADDIN EN.CITE ADDIN EN.CITE.DATA (8)
An understanding of any one of these pathways would be useful in the development of a microvascular network, and understanding how these processes occur in concert could potentially provide a more accurate picture of how angiogenesis both occurs in vivo and may be manipulated to augment the development of TEBVs with structural characteristics that more closely resemble native tissue. This experiment investigates the effects of a 3-D co-cultured fibrin hydrogel under 3-D cyclic strain. The effects of SMCs on angiogenesis The effects of SMCs on angiogenesis muscular human artery.
Hypothesis and specific aims
It is our hypothesis that within a dynamic culture environment the homogenous addition of SMCs to the extracellular matrix will augment the development and invasion of ECs sprouts into a fibrin hydrogel.
SPECIFIC AIM #1: Develop/ identify a co-culture model for angiogenesis.
Dr Greislers lab has extensive experience with in vitro angiogenesis and in particular within fibrin hydrogels. Fibrin is a relevant scaffold material to use in this study as it has been shown to have greater organization and alignment than other biopolymers (i.e. collagen) which improves matrix deposition which makes the mechanical properties of TEBVs more closely resemble a human artery. ADDIN EN.CITE Isenberg200677717Isenberg, B. C.Williams, C.Tranquillo, R. T.Department of Chemical Engineering & Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.Small-diameter artificial arteries engineered in vitroCirc ResCirc Res25-359812006/01/07AnimalsArteries/*cytology/physiologyBiocompatible MaterialsBiomechanicsBioreactorsBlood CirculationCollagenEndothelium, Vascular/physiologyFibrinHumansMuscle, Smooth, Vascular/physiologyPolymersTissue Engineering/*methods2006Jan 61524-4571 (Electronic)16397155http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1639715598/1/25 [pii]
10.1161/01.RES.0000196867.12470.84eng(5)
In this study, HUVECs will be used due to well documented angiogenic behavior and they have been shown to be capable of producing very stable networks of microvessels in engineered tissue. ADDIN EN.CITE Koike200416161617Koike, N.Fukumura, D.Gralla, O.Au, P.Schechner, J. S.Jain, R. K.Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.Tissue engineering: creation of long-lasting blood vesselsNatureNature138-942869792004/03/12AnimalsBiological MarkersBlood Vessels/*cytology/*physiologyCapillary PermeabilityCell DifferentiationCell LineCells, CulturedCoculture TechniquesEndothelial Cells/cytology/physiologyHumansMesenchymal Stem Cells/cytology/physiologyMicePerfusionRegenerative Medicine/methodsTissue Engineering/*methodsUmbilical Veins/cytology2004Mar 111476-4687 (Electronic)15014486http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1501448610.1038/428138a
428138a [pii]eng(10)
SMCs are added to more accurately study the local environment of ECs within the tunica media of native and engineered blood vessels. It has been shown that SMCs produce matrix compounds (i.e. elastin and collagen) in fibrin hydrogels which both structurally stabilizes and adds compliance to engineered blood vessels. ADDIN EN.CITE Isenberg200677717Isenberg, B. C.Williams, C.Tranquillo, R. T.Department of Chemical Engineering & Materials Science, University of Minnesota, Minneapolis, MN 55455, USA.Small-diameter artificial arteries engineered in vitroCirc ResCirc Res25-359812006/01/07AnimalsArteries/*cytology/physiologyBiocompatible MaterialsBiomechanicsBioreactorsBlood CirculationCollagenEndothelium, Vascular/physiologyFibrinHumansMuscle, Smooth, Vascular/physiologyPolymersTissue Engineering/*methods2006Jan 61524-4571 (Electronic)16397155http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1639715598/1/25 [pii]
10.1161/01.RES.0000196867.12470.84eng(5) Additionally, work within Dr Greislers lab (manuscript in preparation) indicates that pelleted ECs and SMCs co-cultured in static fibrin hydrogel demonstrate greater overall sprout lengths and durability over 7 days.
Although human SMC may represent greater potential future relevance, canine carotid SMCs were chosen due to their accessibility and due to Dr. Greislers labs experience and expertise with handling these cells. These data will also be relevant to future canine implant studies.
SPECIFIC AIM #2: Develop/ identify a bioreactor capable of generating 10% cyclic distension.
Recently, Dr. Greislers lab developed a bioreactor system with a Windkessel effect-based pump used to generate 10% cyclic distension in TEBV analogs. This same system shall be employed in this experiment. Ten percent mechanical cyclic strain has been reported as a value sufficient to elicit mechanical cellular stimulation. ADDIN EN.CITE Seliktar200099917Seliktar, D.Black, R. A.Vito, R. P.Nerem, R. M.Institute for Bioengineering & Bioscience, Georgia Institute of Technology, Atlanta 30332-0363, USA. dror@boz.gatech.eduDynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitroAnn Biomed EngAnn Biomed Eng351-622842000/06/28AnimalsBiocompatible MaterialsBiomechanicsBiomedical Engineering/instrumentationBioreactors*Blood Vessel ProsthesisCells, CulturedCollagenGelsMaterials TestingMuscle, Smooth, Vascular/cytologyRats2000Apr0090-6964 (Print)10870892http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10870892eng(11)
SPECIFIC AIM #3: Identify and quantify sprouting
The population of cellular components used in these vascular analogs will be confirmed immunohistochemically prior to use. In hydrogels with a thickness >1 mm immunohistochemical identification of angiogenic sprouts with fluorescently labeled antibodies (>150kD) after fabrication will not be readily achievable. This fact is due to steric limitations of the antibody causing poor penetration and subsequent removal. As such identifying the angiogenic sprouts immunohistochemically will likely result in prohibitively low signal and high background fluorescence even with confocal microscopy. Although sectioning and subsequent staining is possible, the integrity of the very fragile capillary sprouts present within these hydrogels could be in jeopardy during the sectioning process. As such, pre-labeling each cell type with a specific fluorescent surface label could identify sprout behavior within intact hydrogels Dr Greisler has shown that PKH can be successfully used to track endothelial cells for >45 days with minimal signal loss and cell viability loss. ADDIN EN.CITE Fox199915151517Fox, D.Kouris, G. J.Blumofe, K. A.Heilizer, T. J.Husak, V.Greisler, H. P.Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA.Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantationJ Surg ResJ Surg Res9-168611999/08/24AnimalsCell Count/drug effectsCell Division/drug effectsCell Survival/drug effectsCell TransplantationDogsDose-Response Relationship, DrugEndothelium, Vascular/*cytology*Fluorescent Dyes/pharmacology*Organic ChemicalsOsmolar ConcentrationTime FactorsTransplantation, Autologous1999Sep0022-4804 (Print)10452862http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1045286210.1006/jsre.1999.5597
S0022-4804(99)95597-X [pii]eng(12) Although sprouting may occur with convolutions and in a 3-D fashion, quantifying the pellets sprouting by means of a 2-D image and radial grid is reasonable if both treatment and control groups are quantified in the same fashion. ADDIN EN.CITE ADDIN EN.CITE.DATA (13)
Research design and methods
Cell Culture: HUVECs, will be seeded at 5.0x105 cells/flask and grown in fibronectin coated (2.5mg/cm2) t75 flasks in complete EGM media (comprised of proprietary concentrations of: EGM base medium and bovine brain extract, recombinant human Epidermal Growth Factor (rhEGF), hydrocortisone, Gentamicin, and amphotericin) until 75% confluent. The cells will then be transitioned to an M199-based media for the remaining culture until experimental use. The transition me d i a w i l l b e c o m p r i s e d o f M 1 9 9 s u p p l e m e n t e d w i t h L - G l u t a m i n e , H e p e s s a l t s , E a r l e s s a l t s , 2 0 % f e t a l b o v i n e s e r u m , s t r e p t o m y c i n / p e n i c i l l i n ( 1 0 0 g / m L ) , a n d f u n g i s o n e ( 2 5 0 g / m L ) . T h i s s o l u t i o n w i l l b e p a s s e d t h r o u g h a 0 . 2 2 f i l t e r a n d t h e n f u r t h e r e n h a n c e d with rhEGF (10ng/mL). This protocol allows HUVECs to be cultured in vitro without obvious phenotypic de-differentiation in passages 2-6 and retains viability in M199 based hydrogels. SMCs previously obtained from the media of canine carotid arteries by Dr. Greislers lab well established IACUC approved canine protocols will be used in this model. SMCs will be cultured in similar fashion with two exceptions. First SMCs will not require fibronectin coated t75s, and the SMC culture media will be comprised of DMEM supplemented with 10% fetal bovine serum, sodium pyruvate ( 1mM ), Gentamicin (50 mg/mL), and non-essential Amino acids (0.1 mM). Cultures will be incubated at 37C, 100% humidity, and 5% CO2 with regular media changes every 3 days. Cells will be t r a n s f e r r e d f r o m c u l t u r e f l a s k s u s i n g a s h o r t d i g e s t i o n ( d"1 0 m i n u t e ) t r y p s i n - E D T A . F o r c o n s i s t e n t c e l l u l a r b e h a v i o r , o n l y p a s s a g e s 2 - 6 w i l l b e u s e d i n t h e s e e x p e r i m e n t s .
C e l l I d e n t i f i c a t i o n : P r i o r t o e x p e r i m e n t a l u s e , E C a n d S M C p o p u l a t i o n s w i l l b e i d e n t i fied by immunohistochemistry. ECs will be labeled with a 1O antibody of either rabbit anti-vWF/Factor VIII or rabbit anti-human cd31 and subsequently labeled with the fluorescent 2O antibody flouroscein conjugated goat anti-rabbit. SMCs will be identified with a n t i - s m o o t h m u s c l e - a c t i n 1 O a n t i b o d i e s a n d f l u o r e s c e n t r h o d a m i n e l a b e l e d g o a t a n t i - m o u s e 2 O a n t i b o d i e s . C u l t u r e s , > 9 5 % p u r e , w i l l b e u s e d f o r a n g i o g e n e s i s a s s a y s .
C e l l L a b e l i n g : S e p a r a t e E C a n d S M C p o p u l a t i o n s w i l l b e l a b e l e d p r i o r t o p e l l e t i n g w i t h e ither membrane bound immunoflourescent PHK 26 or 67. These surface dyes, 20mM, and BAECs will be suspended in Diluent C, and the labeling process halted with the complete growth media. The PHK 26 or 67 stains will later be detected with TRIT-C and FIT-C imaging, respectively
Pellet Formation: An EC cell pellet will be created by placing 37.5 L of 1% sterile methylcellulose solution into a cell suspension comprised of 2,000 HUVECs in 112.5 L growth media. The (1:3) ratio of methylcellulose to cell suspension will result in a solution with a final concentration of 0.25% methylcellulose. This solution will be placed in a 96-well round-bottom culture plate and incubated 24 hours allowing cell aggregation. Pelleted ECs will be transferred from their round bottom culture plate to a centrifugation tube and spun at 250 RPM for two minutes. After the supernatant solution is removed, the pellets will be ready for use in TEBVs.
TEBV Formation: All TEBVs will be formed in a culture hood using strict sterile technique. The labeled EC pellets will be re-suspended in M199 medium supplemented with L-Glutamine, Hepes salts, and Earles salts. Labeled SMCs will be added to the solution along with fibrinogen, heparin, growth factors, and aprotinin. Thrombin dissolved in an equal volume of the same base medium will then be added to the suspension yielding a final concentration of EC pellets (20 pellets/mL), SMCs (100k /mL), Fibrinogen (2.5mg/mL), Thrombin (0.32 U/mL), Heparin (5U/mL), Vascular Endothelial Growth Factor (VEGF) (1 ng/mL), Fibroblast Growth Factor-1 (FGF-1) (10ng/mL), and Aprotinin (100KIU/mL). As soon as the components are thoroughly mixed they will be added to a TEBV mold. The mold will be comprised of five parts 1) an outer glass cylinder (3cm long x 8 mm I.D.), 2) an inner glass mandrel (3cm long x 3mm O.D.), covering the mandrel 3) a sterile silicon sleeve (2 cm x 3.15 mm I.D.x 3.55 mm 50 D) that has been etched in 10N HCl for 1 hour followed by buffered washes until neutral pH,7) two sterile silicone stoppers for both open ends of the outer cylinder, and 5) an 18 G needle to equalize the pressure within the mold and air evacuation as both stoppers close the cross-linking hydrogel into the mold. The mold will then be gently rolled for 4 minutes to ensure equal distribution of EC pellets and individual SMCs. After 8 minutes the hydrogel is careful removed from the mold and placed within assay media comprised of all same reagents and concentrations as the hydrogel except fibrinogen or thrombin for another 8 minutes to allow final equilibration. Manipulated by their silicone sleeves alone these TEBV analogs will then be attached to the inlet and outlet mounting pins within the bioreactor chamber and sutured into place. The constructs will then be covered with assay media, which will be replaced every 3 days.
Dynamic culture: The bioreactor, sealed with exception of 0.22 filter vent port will be placed within a 37C incubator with 100% humidity, and 5% CO2. The external portion of each TEBVs inlet and outlet mounting pin will be attached to sterile silicone tubing and perfused with phosphate buffered saline until all air has been removed from the perfusion tubing. At this point, Dr Greislers lab novel Windkessel effect pump system will be engaged delivering fluid pulsations through the perfusion tubing sufficient enough to distend the thin silicone sleeves by 10% of the silicones sleeves original volume.
Quantification: Angiogenesis will be documented at Day 7 by measuring average sprout length, sprout number by fluoroscopy at 4x microscope and a color digital camera. Images will then be transferred to Adobe Photoshop v 5.0 software where a 36 spoke radial grid (one every 10) will be overlaid over each image. The number of sprouts that cross a grid line and the distance of furthest crossing will be documented. Additionally the number of sprouts >30 m in diameter will also be calculated. The sprout ultra-structure will be analyzed confocal microscopy with subsequent 3-D reconstructions of angiogenic sprouts using the NIHs Image J software. The samples that appear to have large multi-cellular sprouts will be sent for TEM sectioning and imaging to confirm lumen formation.
Statistics: The average length of sprout, number of sprouts, and number of sprouts with diameter >30 m will be tabulated. The values for static and dynamic culture conditions will be compared using student t-test with equal variance. P values < 0.05 will be considered significant.
Anticipated results and interpretation
Within a dynamic culture environment the homogenous addition of SMCs to the extracellular matrix will augment the development and invasion of EC sprouts into a fibrin hydrogel.
ADDIN EN.REFLIST 1. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med.138:745-53. 1973.
2. Syedain ZH, Weinberg JS, Tranquillo RT. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A.105:6537-42. 2008.
3. Barron V, Lyo ! " # + . / 0 5 6 9 Y y " ` Q S Z [ a b k ƹӘwwi[[[[[[ h{ CJ OJ QJ ^J aJ h d h{ 5OJ QJ ^J h{ >*CJ OJ QJ ^J aJ #h d h{ >*CJ OJ QJ ^J aJ h d h{ CJ OJ QJ ^J aJ h d h{ 5OJ QJ \^J h{ 5OJ QJ \^J h7 h{ OJ QJ ^J h d h{ OJ QJ ^J !h d h{ 5>*OJ QJ \^J h{ 5>*OJ QJ \^J ! " # / 0 5 6 G H b c ] ^gd{ $
! ] a$gd{ $a$gd{ gd{ I J M N O b c J j I h 9 w a b ߦ߇ hL? h{ CJ OJ QJ ^J aJ h d h{ 5OJ QJ ^J )j h{ CJ OJ QJ U^J aJ h d h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH uh{ CJ OJ QJ ^J aJ #j h{ CJ OJ QJ U^J aJ .b v
" 6 7 V e v w / 3 5 J X _ g h
! - M P s { h. h{ CJ OJ QJ ^J aJ hG h{ CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ h\ h{ CJ OJ QJ ^J aJ K A E W # W X Y \ 5 6 G H W ` b µᤚyhWG h8f h{ 5>*OJ QJ ^J !h8f h{ 5>*OJ QJ \^J !h/6l h{ 5>*OJ QJ \^J hL h{ CJ OJ QJ ^J aJ h/6l h{ 5OJ QJ \^J h{ OJ QJ ^J h d h{ CJ OJ QJ ^J aJ h d h{ OJ QJ ^J h d h{ 5OJ QJ ^J hS;5 h{ CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ h\ h{ CJ OJ QJ ^J aJ b c } F R S T " $ & ' ' "' #' %' ' ' ' ' ( * , - - - - . p. ϾϾϾϩϾϾϾϾϗsϗϗ hS h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ )hx h{ B*CJ OJ QJ ^J aJ ph hx h{ CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ #h"2 h{ 5CJ OJ QJ ^J aJ hL h{ CJ OJ QJ ^J aJ -p. y. . . . . . . . . . . . / / :/ ;/ $> <> U> c> n> > > > > > > > > > > > > > > > > > > > > ? ϧϧ )j h{ CJ OJ QJ U^J aJ h h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u)j8 h{ CJ OJ QJ U^J aJ #j h{ CJ OJ QJ U^J aJ h{ CJ OJ QJ ^J aJ h-n0 h{ CJ OJ QJ ^J aJ 2? ? ? }? ? ? ? ? ? @ @ @ (@ 8@ t@ @ @ @A BA DA B D F G G G G G G *G ,G G G G H H H H H H пᮜwff hx h{ CJ OJ QJ ^J aJ #h"2 h{ 5CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ h h{ CJ OJ QJ ^J aJ h d h{ CJ OJ QJ ^J aJ hS h{ CJ OJ QJ ^J aJ h h{ CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ 'H H H H H H sI vI wI I I I I I J JJ \J J J L N P
Q Q Q Q Q Q Q Q Q طwfUطUطط h_ h{ CJ OJ QJ ^J aJ hIm5 h{ CJ OJ QJ ^J aJ hoV h{ CJ OJ QJ ^J aJ hoV h{ 5OJ QJ ^J h{ 5CJ OJ QJ ^J aJ #h"2 h{ 5CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ )jL h{ CJ OJ QJ U^J aJ Q Q Q Q Q Q Q R R R S S T T T T !T *OJ QJ \^J )h; h{ 5>*CJ OJ QJ \^J aJ h5 h{ CJ OJ QJ ^J aJ h{ 6CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ h_ h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ )j4 h{ CJ OJ QJ U^J aJ T T T U U U U U 6U 7U 8U hU qU U U U U U U U V &V MV \V ~V V V X Z \ ] ] ] ] ] ] ] ] ^ 2^ 9^ ͻ{{h{ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ hY h{ CJ OJ QJ ^J aJ h{ 6CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ #hM h{ 5CJ OJ QJ ^J aJ hE2 h{ CJ OJ QJ ^J aJ #hE2 h{ 5CJ OJ QJ ^J aJ h{ 5CJ OJ QJ ^J aJ (9^ <^ P^ Q^ U^ v^ w^ x^ ` b d f if jf nf of qf f f f f f f f g g ?g Fg Gg ag g g h j l n n n n n n n n o o $o *o o o o o p Up p p p p p ϼϼ h{ 5CJ OJ QJ ^J aJ #h d h{ 5CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u#j h{ CJ OJ QJ U^J aJ hY h{ CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ 9p p p p p q q q q q r r
r r *r 3r ?r @r t v x x x x x x x y *y .y *OJ QJ ^J !hn h{ 5>*OJ QJ \^J h{ 5>*OJ QJ \^J h{ CJ OJ QJ ^J aJ hs h{ CJ OJ QJ ^J aJ %h{ CJ OJ QJ ^J aJ mH nH u)j hs h{ CJ OJ QJ U^J aJ #j h{ CJ OJ QJ U^J aJ )j2= h{ CJ OJ QJ U^J aJ B J ƌ nj T | ~ : ; : < L N j & 9 J Ο џ f ﹹ &h\ h{ 5>*CJ OJ QJ ^J aJ #h\ h{ CJ H*OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ #h\ h{ 5CJ OJ QJ ^J aJ #h\ h{ CJ H*OJ QJ ^J aJ #h\ h{ 6CJ OJ QJ ^J aJ h\ h{ CJ OJ QJ ^J aJ 1 9 ʥ ˥ G w R S U 0^`0gd{ $
! a$gd{ gd{ f } ݣ f j ɥ ʥ ˥ ڸڒ~m]LL> h{ CJ OJ QJ ^J aJ h h{ CJ OJ QJ ^J aJ h h{ 5>*OJ QJ ^J !h h{ 5>*OJ QJ \^J &h\ h{ >*CJ OJ QJ \^J aJ #h\ h{ CJ OJ QJ \^J aJ &h\ h{ 5CJ OJ QJ \^J aJ &h\ h{ 5>*CJ OJ QJ ^J aJ h{ CJ OJ QJ ^J aJ h\ h{ CJ OJ QJ ^J aJ (h\ h{ CJ OJ QJ ^J aJ mH sH G w R S T U hz !h{ CJ OJ QJ ^J mH nH uU'h bM h{ CJ OJ QJ ^J mH nH uh{ OJ QJ ^J j h{ OJ QJ U^J ns E, Stenson-Cox C, McHugh PE, Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng.31:1017-30. 2003.
4. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science.231:397-400. 1986.
5. Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res.98:25-35. 2006.
6. Ziegler T, Alexander RW, Nerem RM. An endothelial cell-smooth muscle cell co-culture model for use in the investigation of flow effects on vascular biology. Ann Biomed Eng.23:216-25. 1995.
7. Joung IS, Iwamoto MN, Shiu YT, Quam CT. Cyclic strain modulates tubulogenesis of endothelial cells in a 3D tissue culture model. Microvasc Res.71:1-11. 2006.
8. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol.23:879-84. 2005.
9. Von Offenberg Sweeney N, Cummins PM, Cotter EJ, Fitzpatrick PA, Birney YA, Redmond EM, et al. Cyclic strain-mediated regulation of vascular endothelial cell migration and tube formation. Biochem Biophys Res Commun.329:573-82. 2005.
10. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Tissue engineering: creation of long-lasting blood vessels. Nature.428:138-9. 2004.
11. Seliktar D, Black RA, Vito RP, Nerem RM. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng.28:351-62. 2000.
12. Fox D, Kouris GJ, Blumofe KA, Heilizer TJ, Husak V, Greisler HP. Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantation. J Surg Res.86:9-16. 1999.
13. Vernon RB, Sage EH. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc Res.57:118-33. 1999.
, 1h / =!"#$% 8 D Syedain200866617Syedain, Z. H.Weinberg, J. S.Tranquillo, R. T.Departments of Chemical Engineering and Materials Science and Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissueProc Natl Acad Sci U S AProc Natl Acad Sci U S A6537-42105182008/04/26*Adaptation, PhysiologicalAnimalsBlotting, WesternCarotid Arteries/cytologyCattleCells, CulturedCollagen/metabolismConnective Tissue/*growth & developmentDermis/cytology/metabolismEnzyme ActivationFibrin/*metabolismFibroblasts/cytology/metabolismHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1/metabolismMitogen-Activated Protein Kinase 3/metabolismSwineTensile StrengthTime FactorsTissue Engineering/*methods*Tissue Scaffolds2008May 61091-6490 (Electronic)18436647http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1843664723733560711217105 [pii]
10.1073/pnas.0711217105eng Joung200614141417Joung, I. S.Iwamoto, M. N.Shiu, Y. T.Quam, C. T.Department of Bioengineering, University of Utah, 20 South 2030 East, BPR Room 506, Salt Lake City, 84112, USA.Cyclic strain modulates tubulogenesis of endothelial cells in a 3D tissue culture modelMicrovasc ResMicrovasc Res1-117112005/12/22Actins/metabolismAnimalsAorta, Thoracic/cytologyCapillaries/cytology/physiologyCattleCell Culture TechniquesCell LineCell MovementCollagen/pharmacologyElasticityEndothelium, Vascular/*cytology/*physiologyGelsImaging, Three-DimensionalImmunohistochemistryMechanotransduction, Cellular/*physiology*Models, BiologicalNeovascularization, Physiologic/*physiologyPeriodicityPhysical Stimulation/methodsStress, Mechanicalvon Willebrand Factor/metabolism2006Jan0026-2862 (Print)16368114http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16368114S0026-2862(05)00111-1 [pii]
10.1016/j.mvr.2005.10.005eng 8 D Syedain200866617Syedain, Z. H.Weinberg, J. S.Tranquillo, R. T.Departments of Chemical Engineering and Materials Science and Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissueProc Natl Acad Sci U S AProc Natl Acad Sci U S A6537-42105182008/04/26*Adaptation, PhysiologicalAnimalsBlotting, WesternCarotid Arteries/cytologyCattleCells, CulturedCollagen/metabolismConnective Tissue/*growth & developmentDermis/cytology/metabolismEnzyme ActivationFibrin/*metabolismFibroblasts/cytology/metabolismHumansMAP Kinase Signaling SystemMitogen-Activated Protein Kinase 1/metabolismMitogen-Activated Protein Kinase 3/metabolismSwineTensile StrengthTime FactorsTissue Engineering/*methods*Tissue Scaffolds2008May 61091-6490 (Electronic)18436647http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1843664723733560711217105 [pii]
10.1073/pnas.0711217105eng Levenberg200588817Levenberg, S.Rouwkema, J.Macdonald, M.Garfein, E. S.Kohane, D. S.Darland, D. C.Marini, R.van Blitterswijk, C. A.Mulligan, R. C.D'Amore, P. A.Langer, R.Department of Biomedical Engineering, Technion 32000, Haifa, Israel. shulamit@bm.technion.ac.ilEngineering vascularized skeletal muscle tissueNat BiotechnolNat Biotechnol879-842372005/06/21AnimalsBlood Vessels/physiologyCells, CulturedCoculture TechniquesEmbryo, Mammalian/cytologyEndothelial Cells/physiologyEndothelium, Vascular/physiologyFibroblasts/physiologyHumansMiceMuscle, Skeletal/*blood supplyMyoblasts, Skeletal/physiology*Neovascularization, PhysiologicTissue Engineering/*methods2005Jul1087-0156 (Print)15965465http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15965465nbt1109 [pii]
10.1038/nbt1109engLevenberg200588817Levenberg, S.Rouwkema, J.Macdonald, M.Garfein, E. S.Kohane, D. S.Darland, D. C.Marini, R.van Blitterswijk, C. A.Mulligan, R. C.D'Amore, P. A.Langer, R.Department of Biomedical Engineering, Technion 32000, Haifa, Israel. shulamit@bm.technion.ac.ilEngineering vascularized skeletal muscle tissueNat BiotechnolNat Biotechnol879-842372005/06/21AnimalsBlood Vessels/physiologyCells, CulturedCoculture TechniquesEmbryo, Mammalian/cytologyEndothelial Cells/physiologyEndothelium, Vascular/physiologyFibroblasts/physiologyHumansMiceMuscle, Skeletal/*blood supplyMyoblasts, Skeletal/physiology*Neovascularization, PhysiologicTissue Engineering/*methods2005Jul1087-0156 (Print)15965465http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15965465nbt1109 [pii]
10.1038/nbt1109engVon Offenberg Sweeney200517171717Von Offenberg Sweeney, N.Cummins, P. M.Cotter, E. J.Fitzpatrick, P. A.Birney, Y. A.Redmond, E. M.Cahill, P. A.Vascular Health Research Centre, Faculty of Science and Health, Dublin City University, Dublin 9, Ireland.Cyclic strain-mediated regulation of vascular endothelial cell migration and tube formationBiochem Biophys Res CommunBiochem Biophys Res Commun573-8232922005/03/02Adaptation, Physiological/physiologyAnimalsAorta/cytology/physiologyBlood Vessels/*growth & developmentCattleCell Culture Techniques/*methodsCell Differentiation/physiologyCell Movement/*physiologyCells, CulturedElasticityEndothelial Cells/*physiologyIntegrins/metabolismMatrix Metalloproteinases/metabolismMechanotransduction, Cellular/*physiologyNeovascularization, Physiologic/*physiologyPeriodicityPhysical Stimulation/methodsStress, MechanicalTissue Engineering/methods2005Apr 80006-291X (Print)15737624http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15737624S0006-291X(05)00258-5 [pii]
10.1016/j.bbrc.2005.02.013eng ` D Levenberg200588817Levenberg, S.Rouwkema, J.Macdonald, M.Garfein, E. S.Kohane, D. S.Darland, D. C.Marini, R.van Blitterswijk, C. A.Mulligan, R. C.D'Amore, P. A.Langer, R.Department of Biomedical Engineering, Technion 32000, Haifa, Israel. shulamit@bm.technion.ac.ilEngineering vascularized skeletal muscle tissueNat BiotechnolNat Biotechnol879-842372005/06/21AnimalsBlood Vessels/physiologyCells, CulturedCoculture TechniquesEmbryo, Mammalian/cytologyEndothelial Cells/physiologyEndothelium, Vascular/physiologyFibroblasts/physiologyHumansMiceMuscle, Skeletal/*blood supplyMyoblasts, Skeletal/physiology*Neovascularization, PhysiologicTissue Engineering/*methods2005Jul1087-0156 (Print)15965465http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15965465nbt1109 [pii]
10.1038/nbt1109eng V D Vernon199910101017Vernon, R. B.Sage, E. H.Department of Biological Structure, School of Medicine, University of Washington, Seattle, 98195-7420, USA.A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matricesMicrovasc ResMicrovasc Res118-335721999/03/02AnimalsCattleCell Movement/drug effectsClone CellsCollagenEndothelial Growth Factors/pharmacologyEndothelium, Vascular/*cytology/drug effects/growth & developmentExtracellular Matrix/physiologyFibroblast Growth Factor 2/pharmacologyGelsLymphokines/pharmacologyMitomycin/pharmacology*Models, Cardiovascular*Neovascularization, Physiologic/drug effectsVascular Endothelial Growth Factor AVascular Endothelial Growth Factors1999Mar0026-2862 (Print)10049660http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10049660S0026-2862(98)92122-7 [pii]
10.1006/mvre.1998.2122eng x 2 & 6 F V f v 2 ( & 6 F V f v & 6 F V f v & 6 F V f v & 6 F V f v & 6 F V f v & 6 F V f v 8 X V ~ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 0 @ 6 6 6 6 6 _HmH nH sH tH @ ` @ { N o r m a l CJ _HaJ mH sH tH D A D D e f a u l t P a r a g r a p h F o n t R i R T a b l e N o r m a l 4
l 4 a ( k ( N o L i s t 4 @ 4 { H e a d e r
! H H : B a l l o o n T e x t CJ OJ QJ ^J aJ PK ! [Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;r ØJB+$G]7O٭Vj\{cp/I Dg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½| SˌDإbj|E7C< bʼNp r8fnߧFrI.{1fVԅ$21(t}kJV1/ Ú QL×07#]fV Ih cMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ]
C: = ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j
z'^9J{rJЃ 3Ax|
FU9
i3Q/B)LʾRPx)04N
O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr
Zy 4Sw3?Wӊ hPxzSq]y
> 1 b b p. .= ? H Q T 9^ p y f U T V W X Y Z \ ] ^ _ ` a b c d e g h c U U [ f N R # ' # # @% 2, 6, , ,3 03 3 3 3 3 3 4 4 4 4 4 6 ; ; = = = = = ? E E nF ~F F F F K R R \S N[ S[ \ c c $g m m :r y y z z z z z < > QQQDQQQQQQDQQDQQQDQQQDQQQQQQQDQ 8 @ 0 (
B
S ?
%
U _ 5 5 < < J *J :S FS c c d d e e f )f q q | "| #} (} t} v} } } } } } } ~ ~ @ C H M d i @ =
C
H H gJ {J h[ [ n n { { ' * k p , ' 3 @ 3 3 3 3 3 3 3 3 3 3 3 3 3 3 / ; M < @ @
z3 dY z : { 7 )K 3Q > @ @ 5 6 | } > @
@ @ @ @ @ (@ @ U n k n o w n G . [x T i m e s N e w R o m a n 5 S y m b o l 3. . [x A r i a l 5. . [` ) T a h o m a C., . {$ C a l i b r i L i g h t 7. . {$ C a l i b r i A $ B C a m b r i a M a t h " q h GGŚ z Q ! z Q ! ! 20 3q @P )? { 2 ! x x `Uq S A M P L E B A S I C S C I E N C E A P P L I C A T I O N L U H S R u t s c h m a n , T i n a
Oh +'0 ( 4
T ` l
x $ SAMPLE BASIC SCIENCE APPLICATION LUHS Normal Rutschman, Tina 2 Microsoft Office Word @ F# @ M>@ |LJ@ |LJ z
՜. +,0 ( h p
$ Loyola University Medical Center ! Q ! SAMPLE BASIC SCIENCE APPLICATION Title
! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n p q r s t u v w x y z { | } ~ R o o t E n t r y F sȇ D a t a
o E 1 T a b l e ! W o r d D o c u m e n t . S u m m a r y I n f o r m a t i o n ( D o c u m e n t S u m m a r y I n f o r m a t i o n 8 C o m p O b j r
F Microsoft Word 97-2003 Document
MSWordDoc Word.Document.8 9q